1Bz-LSD

1Bz-LSD, also known as 1-benzoyl-LSD or as SYN-L-018, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).^[1][2] It is thought to be a prodrug of LSD.^[1][2] The drug was patented by Lizard Labs in 2024.^[2] Subsequently, it was encountered online as a novel designer drug in July 2024.^[1] 1Bz-LSD has been sold in the form of blotter tabs and microdots containing 10 μg and 200 μg doses per unit.^[1] 1Bz-LSD is not an explicitly controlled substance in the United States^[3] or in Canada.^[4]

Other names1-Benzoyl-LSD; SYN-L-018

Routes of
administrationOral^[1]

Drug classSerotonergic psychedelic; Hallucinogen

ATC code

• None

Quick facts Clinical data, Other names ...

1Bz-LSD

Clinical data
Other names	1-Benzoyl-LSD; SYN-L-018
Routes of administration	Oral[1]
Drug class	Serotonergic psychedelic; Hallucinogen
ATC code	None
Chemical and physical data
Formula	C27H28N3O2
Molar mass	426.540 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCN(CC)C(=O)[C]1CN(C)[C@@H]2Cc3cn(C(=O)c4ccccc4)c5cccc(C2=C1)c35
InChI InChI=1S/C27H28N3O2/c1-4-29(5-2)26(31)20-14-22-21-12-9-13-23-25(21)19(15-24(22)28(3)16-20)17-30(23)27(32)18-10-7-6-8-11-18/h6-14,17,24H,4-5,15-16H2,1-3H3/t24-/m1/s1 Key:GVGINGNTVRBWSQ-XMMPIXPASA-N

Close